Wednesday, February 28, 2007 - 18:28

Eric Vivier's team at the marseille-luminy Immunology Centre and Innate Pharma researchers announced the development of a new animal model dedicated to studying NK cell activity.

AttachmentSize
PR in english90.73 KB
CP en français100.82 KB